These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 7471152)
1. [Essential choline phospholipids and their effect on HBsAg and selected biochemical tests in cirrhosis of the liver (author's transl)]. Fassati P; Horejsí J; Fassati M; Spízek J; Jezková Z Cas Lek Cesk; 1981 Jan; 120(2):56-60. PubMed ID: 7471152 [No Abstract] [Full Text] [Related]
2. [HBsAG in the ascitic fluid in patients with liver cirrhosis (author's transl)]. Chlumský J; Krtek V; Miksanová R Cas Lek Cesk; 1979 Aug; 118(34):1068-9. PubMed ID: 509462 [No Abstract] [Full Text] [Related]
3. [Use of "Essenciale" in the treatment of liver diseases]. Pogromov AP; Ol'binskaia LI; Antonenko NI; Gitel' NP; Smolianitskiĭ AIa Klin Med (Mosk); 1978 Oct; 56(10):97-101. PubMed ID: 362064 [No Abstract] [Full Text] [Related]
4. [Essential cholinephospholipids in the treatment of virus hepatitis (author's transl)]. Kosina F; Budka K; Kolouch Z; Lazarová D; Truksová D Cas Lek Cesk; 1981 Aug; 120(31-32):957-60. PubMed ID: 7261022 [No Abstract] [Full Text] [Related]
5. [Essential colinephospholipids -- an effective and expedient means of hepatic cirrhos freatment (author's transl)]. Fassati P; Fassati M Cas Lek Cesk; 1975 Oct; 114(40):1243-50. PubMed ID: 1102101 [No Abstract] [Full Text] [Related]
6. [Alkaline phosphatase isoenzymes in evaluation of therapeutic effect of essential cholinephospholipids in hepatic cirrhoses (author's transl)]. Fassati P; Stĕpán J; Fassati M Cas Lek Cesk; 1976 Jan; 115(2-3):72-5. PubMed ID: 766970 [No Abstract] [Full Text] [Related]
8. A study of the prevalence of hepatitis B surface antigen (HBsAg) in cirrhosis of liver by RPHA. Mathur S; Mathur M; Bhandari R; Banerjee K; Kothari D; Mathur A J Assoc Physicians India; 1985 Nov; 33(11):714. PubMed ID: 4093384 [No Abstract] [Full Text] [Related]
9. [Essential phospholipids in the treatment of liver cirrhosis]. Kaláb M; Cervinka J Cas Lek Cesk; 1983 Mar; 122(9):266-9. PubMed ID: 6850742 [No Abstract] [Full Text] [Related]
10. [A preliminary study on the serum HBsAg level in patients with chronic hepatitis B and hepatitis cirrhosis during lamivudine therapy]. Qin LY; Liu KH; Zhang ZH; Wang YZ Zhonghua Gan Zang Bing Za Zhi; 2005 Aug; 13(8):602. PubMed ID: 16092985 [No Abstract] [Full Text] [Related]
11. HBsAg in ascitic fluid of patients with hepatic cirrhosis. Chlumsky J; Krtek V Hepatogastroenterology; 1982 Jun; 29(3):106-7. PubMed ID: 7106693 [No Abstract] [Full Text] [Related]
12. [Results of a long-term study of HBsAg in the blood in chronic liver disease]. Stránský J; Helm R; Hrbác I; Sprincl L; Benda R Vnitr Lek; 1983 Jul; 29(6):565-70. PubMed ID: 6613024 [No Abstract] [Full Text] [Related]
13. [Cirrhosis of the liver and "lymphomas": five new cases (author's transl)]. Paraf A; Karsenti P; Kemeny F; Richard P Ann Med Interne (Paris); 1980; 131(4):235-8. PubMed ID: 7425448 [TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological study of primary hepatocellular carcinoma in relation to liver cirrhosis and HBsAg (author's transl)]. Kimura H; Kako M; Torii M; Takatsuki K; Fujiwara K; Sakai T; Endo Y; Suzuki H; Oda T Nihon Shokakibyo Gakkai Zasshi; 1979 Sep; 76(9):1836-41. PubMed ID: 229285 [No Abstract] [Full Text] [Related]
15. Hepatitis B surface antigen in cirrhosis of liver. Sharma VK; Prasad FC J Indian Med Assoc; 1985 Sep; 83(9):305-7. PubMed ID: 4086851 [No Abstract] [Full Text] [Related]
16. [The effect of atropine on the course of oral glucose tolerance test in patients with liver cirrhosis (author's transl)]. Brodanová M; Andĕl M; Brodan V; Kuhn E; Vondra K Cas Lek Cesk; 1978 Jul; 117(29-30):898-900. PubMed ID: 688315 [No Abstract] [Full Text] [Related]
17. Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine. Sponseller CA; Bacon BR; Di Bisceglie AM Liver Transpl; 2000 Nov; 6(6):715-20. PubMed ID: 11084057 [TBL] [Abstract][Full Text] [Related]
18. [Chronic hepatitis: interest of a classification based on the presence or the absence of HBs Ag, smooth muscle antibody and microsomal antibody (author's transl)]. Poupon R; Petit J; Bodin F; de Saint-Maur PP; Homberg JC; Darnis F Gastroenterol Clin Biol; 1980 Oct; 4(10):666-73. PubMed ID: 7439610 [No Abstract] [Full Text] [Related]
19. [Relationship between ADCC effector cells and the combination therapy of pantethine and lecithin--a proposal for management of patients with HBsAg carrier state (author's transl)]. Murata T; Oniki H; Kimura Y; Komoda T; Yamashita Y; Nakamura S; Koga Y Igaku Kenkyu; 1981 Oct; 51(4):213-23. PubMed ID: 7331739 [No Abstract] [Full Text] [Related]
20. [Antibodies against some bacterial and non-bacterial antigens in chronic hepatitis and cirrhosis of the liver (author's transl)]. Petera V; Zavázal V; Vosmík J Cas Lek Cesk; 1974 Oct; 113(42):1287-9. PubMed ID: 4420991 [No Abstract] [Full Text] [Related] [Next] [New Search]